Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track CPIX with free AI briefings, catalyst countdowns, and dilution alerts.

CPIX · CUMBERLAND PHARMACEUTICALS INC

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$3.9M Cash on Hand
CF+ Cash Runway
Follow CPIX by email Get an email when CPIX reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CPIX, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

🧪 Trial & FDA Catalysts

📊 Drug Pipeline

DrugIndicationMost advanced trialStatus
Conivaptan Hydrochloride
FDA approved Feb 2007 · Vaprisol
Hyponatremia Phase 3 · NCT01451411 Terminated
Ascorbic Acid Autism N/A · NCT00889538 Completed
Ketorolac Pain Phase 4 · NCT01901393 Completed
Ketorolac Tromethamine Arthroscopic Knee Surgery Phase 4 · NCT01650519 Completed
Ibuprofen Arthroscopic Knee Surgery Phase 4 · NCT01650519 Completed
Telavancin Subarachnoid Hemorrhage, Aneurysmal Phase 4 · NCT06119061 Recruiting
Acetylcysteine Acetaminophen Overdose Phase 3 · NCT01118663 Terminated
Vancomycin Bacteremia Phase 3 · NCT02208063 Terminated
135 grams of Crystalline Lactulose Colonoscopy Preparation Phase 2 · NCT02123017 Completed
Squalamine Lactate Ophthalmic Solution, 0.2% Retinal Vein Occlusion Phase 1/2 · NCT02614937 Completed
Split dose preparation Colonoscopy Preparation Phase 2 · NCT01887470 Completed
Ifetroban Scleroderma, Diffuse Phase 2 · NCT02682511 Active not recruiting
Vancomycin or antistaphylococcal penicillin Infections, Gram-Positive Bacterial Phase 2 · NCT00061633 Completed
Ifetroban Sodium Idiopathic Pulmonary Fibrosis Phase 2 · NCT05571059 Recruiting
Full dose preparation Colonoscopy Preparation Phase 2 · NCT01887470 Completed
Crystalline Lactulose Colonoscopy Phase 2 · NCT01650870 Completed

Also used in these trials (approved or third-party drugs, not CPIX's own candidates): Kojic Acidskin Lightening, Acetaminophen, Indomethacin, Nafcillin Sodium, Daptomycin, Cefazolin, Ranibizumab.

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

CPIX holds $3.9M in cash and short-term investments (as of Jun 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CPIX files for a raise →

👥 Who Owns CPIX

Insiders 41% Institutions (40 holders) 21.2% Public and other holders 37.8%
HolderTypeShares% of sharesAs of
A J Kazimi
Chairman and CEO, Director, 10% owner · +568,000 options
Insider 5,695,310 37.98% 2026-03-16
Kenneth Krogulski
Director
Insider 302,338 2.02% 2026-03-18
Joseph C Galante
Director
Insider 63,656 0.42% 2026-03-18
James Jones
Director
Insider 46,863 0.31% 2026-03-18
Caroline Young
Director
Insider 35,109 0.23% 2026-03-18
Martin S JR Brown
Director
Insider 10,300 0.07% 2026-03-18

Share count 14,995,547 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full CPIX picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CPIX and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.